日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens

基于模型的固定剂量多替拉韦方案剂量减少策略比较

Dickinson, Laura; Else, Laura; Venter, Willem D F; Boffito, Marta; Brand, Rhonda; Waitt, Catriona; Hill, Andrew; Khoo, Saye

Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis

包皮紧密连接的基因表达不受艾滋病毒暴露前预防的影响

Emily L Webb, Stefan Petkov, Heejin Yun, Laura Else, Limakatso Lebina, Jennifer Serwanga, Azure-Dee A P Pillay, Thabiso B Seiphetlo, Susan Mugaba, Patricia Namubiru, Geoffrey Odoch, Daniel Opoka, Andrew S Ssemata, Pontiano Kaleebu, Saye Khoo, Neil Martinson, Julie Fox, Clive M Gray, Carolina Herrera

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial

撒哈拉以南非洲地区针对插入性行为的 HIV 暴露前预防按需用药剂量探索研究:来自 CHAPS 开放标签随机对照试验的结果

Carolina Herrera, Jennifer Serwanga, Laura Else, Lebina Limakatso, Daniel Opoka, Andrew S Ssemata, Azure-Dee Pillay, Patricia Namubiru, Thabiso B Seiphetlo, Geoffrey Odoch, Susan Mugaba, Portia Seatlholo, Amara Alieu, Sujan Dilly Penchala, Richard Muhumuza, Berenice Alinde, Stefan Petkov, Kyle O'Hag

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

β-d-N4-羟基胞苷(前药莫努匹拉韦的母核苷)在重症急性呼吸综合征冠状病毒2感染患者非血浆隔室中的药代动力学

FitzGerald, Richard; Dickinson, Laura; Else, Laura; Fletcher, Thomas; Hale, Colin; Amara, Alieu; Walker, Lauren; Penchala, Sujan Dilly; Lyon, Rebecca; Shaw, Victoria; Greenhalf, William; Bullock, Katie; Lavelle-Langham, Lara; Reynolds, Helen; Painter, Wendy; Holman, Wayne; Ewings, Sean; Griffiths, Gareth; Khoo, Saye

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue

替诺福韦和替诺福韦艾拉酚胺用于包皮组织 HIV-1 暴露前预防的临床前评估

Laura Else, Sujan D Penchala, Azure-Dee Pillay, Thabiso B Seiphetlo, Limakatso Lebina, Christian Callebaut, Suks Minhas, Roland Morley, Tina Rashid, Neil Martinson, Julie Fox, Saye Khoo, Carolina Herrera; CHAPS Consortium

The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva

开发并验证一种新型 LC-MS/MS 方法,用于同时定量测定人血浆和唾液中的 Molnupiravir 及其代谢物 β-d-N4-羟基胞苷

Alieu Amara, Sujan Dilly Penchala, Laura Else, Colin Hale, Richard FitzGerald, Lauren Walker, Rebecca Lyons, Tom Fletcher, Saye Khoo

Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS

使用 LC-MS/MS 同时定量测定干血和干乳斑中的拉米夫定、恩曲他滨和替诺福韦的方法的开发、验证和临床应用

Catriona Waitt, Sujan Diliiy Penchala, Adeniyi Olagunju, Alieu Amara, Laura Else, Mohammed Lamorde, Saye Khoo

Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients

达芦那韦抑制商可预测接受过人类免疫缺陷病毒感染的蛋白酶抑制剂治疗的患者对以达芦那韦为基础的挽救疗法的 48 周病毒学应答

José Moltó, José R Santos, Nuria Pérez-Alvarez, Samandhy Cedeño, Cristina Miranda, Saye Khoo, Laura Else, Josep Maria Llibre, Marta Valle, Bonaventura Clotet